[144] Natural Resource Partners L.P. SEC Filing

Rhea-AI Filing Summary

Natural Resource Partners L.P. (NRP) filed a Form 144 notifying the proposed sale of 8,607 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $862,743.30. The filing lists 13,138,097 shares outstanding and an approximate sale date of 09/08/2025 on the NYSE. The shares were acquired on 02/15/2024 through restricted stock vesting under a registered plan and were received as compensation. The filer reports no securities sold in the past three months and affirms not possessing undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Small planned sale of vested restricted shares by an insider; economically modest relative to total shares outstanding.

The proposed sale of 8,607 shares equals roughly 0.066% of the reported 13,138,097 shares outstanding, indicating limited direct market impact. The securities were granted as restricted stock that vested on 02/15/2024 and are being sold through a major brokerage, which suggests routine liquidity by the holder rather than a corporate financing action. No prior sales in the last three months were reported, which reduces signals of accelerated liquidation.

Corporate Governance Expert

TL;DR: Transaction appears procedural and compliant with Rule 144 disclosure norms; no governance red flags in the filing itself.

The Form 144 documents a Rule 144 notice for shares obtained via restricted stock vesting under a registered plan and lists the broker and planned sale date. The signer affirms absence of undisclosed material adverse information, and the filing notes no recent sales to aggregate. The filing lacks details on the filers relationship to the issuer, which is typically included but may be present elsewhere; based solely on this document, the disclosure meets basic Rule 144 notice requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8607	862743.30	13138097	09/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2024	Restricted stock vesting under a registered plan	Issuer			8607	02/15/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does NRP's Form 144 report about the proposed sale?

The filing discloses a proposed sale of 8,607 common shares with an aggregate market value of $862,743.30 to be executed via Morgan Stanley Smith Barney LLC on or about 09/08/2025.

How and when were the shares being offered acquired?

The shares were acquired on 02/15/2024 through restricted stock vesting under a registered plan and were received as compensation.

What portion of NRP's outstanding shares does this proposed sale represent?

The filing lists 13,138,097 shares outstanding; 8,607 shares represent approximately 0.066% of that total.

Has the filer sold NRP securities in the past three months?

The Form 144 states "Nothing to Report" for securities sold during the past three months.

Does the filing indicate any undisclosed material adverse information?

By signing, the person represents they do not know any material adverse information